In conclusion, Sema3a-CreERT2 is the first genetic mouse tool for the specific targeting of Purkinje fibres and provides a means for the in vivo functional study of Purkinje fibres during ventricular conduction system formation and cardiac arrhythmias. The gene discussed is SEMA3A; the disease is chronic obstructive pulmonary disease.